“…First, MDD is a complex neuropsychiatric disorder that likely involves the dysfunction of a distributed network consisting of multiple limbic and frontal regions (Mayberg, 1997 ; Drevets, 2001 ; Ramirez-Mahaluf et al, 2017 ; Williams, 2017 ). Moreover, within the limbic-frontal network, altered neural spectral activity at different frequency bands—especially the θ band (3–7 Hz) and β+low γ band (30–50 Hz)—has been observed in different mood symptom states (Sani et al, 2018 ; Bijanzadeh et al, 2022 ; Xiao et al, 2023 ) and after DBS (Rao et al, 2018 ; Smart et al, 2018 ; Smith et al, 2022 ). This means that using a scalar neural biomarker computed from a single brain site and a single frequency band (Scangos et al, 2021a ) may not be sufficient for achieving precise MDD symptom regulation.…”